Discovery of oxybisbenzoylamides as a new class of antimalarial agents

We have previously described several potent dual inhibitors of Plasmodium falciparum ( Pf ) growth characterized by the presence of statine, a β-hydroxyl amino acid able to inhibit parasite's plasmepsins (PLMs). While investigating the mechanism of action of these inhibitors, new compounds deri...

Full description

Saved in:
Bibliographic Details
Published in:MedChemComm 2015-06, Vol.6 (6), p.1173-1177
Main Authors: Pancotti, A., Parapini, S., Dell'Agli, M., Gambini, L., Galli, C., Sangiovanni, E., Basilico, N., Bosisio, E., Taramelli, D., Romeo, S.
Format: Article
Language:English
Subjects:
Plasmodium
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have previously described several potent dual inhibitors of Plasmodium falciparum ( Pf ) growth characterized by the presence of statine, a β-hydroxyl amino acid able to inhibit parasite's plasmepsins (PLMs). While investigating the mechanism of action of these inhibitors, new compounds derived from statine were synthesized, which lost the ability to inhibit PLMs, but retained a significant Pf growth inhibition. Further structural simplifications showed that the inhibition of Pf viability was ascribed to a new pharmacophore never described before as antimalarial.
ISSN:2040-2503
2040-2511
DOI:10.1039/C5MD00115C